 Aaron Clauset
Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Faculty | 5 | 2024 | 137 | 1.800 |
Why?
| | Models, Theoretical | 6 | 2019 | 546 | 1.700 |
Why?
| | Social Networking | 5 | 2022 | 33 | 1.630 |
Why?
| | Research Personnel | 3 | 2023 | 155 | 1.580 |
Why?
| | Biological Evolution | 4 | 2013 | 432 | 1.040 |
Why?
| | Body Size | 3 | 2013 | 104 | 0.960 |
Why?
| | Career Mobility | 3 | 2024 | 68 | 0.900 |
Why?
| | Ovarian Neoplasms | 3 | 2024 | 489 | 0.890 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 2024 | 69 | 0.870 |
Why?
| | Ageism | 1 | 2023 | 2 | 0.860 |
Why?
| | Algorithms | 8 | 2024 | 1613 | 0.840 |
Why?
| | Tumor Microenvironment | 2 | 2024 | 631 | 0.820 |
Why?
| | Awards and Prizes | 1 | 2023 | 63 | 0.790 |
Why?
| | Models, Biological | 6 | 2019 | 1722 | 0.760 |
Why?
| | Research | 1 | 2023 | 416 | 0.670 |
Why?
| | Fellowships and Scholarships | 1 | 2022 | 273 | 0.630 |
Why?
| | Plasmodium falciparum | 2 | 2016 | 29 | 0.620 |
Why?
| | Information Services | 1 | 2019 | 47 | 0.620 |
Why?
| | Models, Statistical | 3 | 2020 | 623 | 0.610 |
Why?
| | Informatics | 1 | 2018 | 7 | 0.610 |
Why?
| | Models, Genetic | 2 | 2013 | 593 | 0.610 |
Why?
| | Microbial Consortia | 1 | 2017 | 18 | 0.550 |
Why?
| | Body Weight | 2 | 2013 | 939 | 0.550 |
Why?
| | Mammals | 2 | 2009 | 272 | 0.530 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 742 | 0.520 |
Why?
| | Community Networks | 1 | 2016 | 56 | 0.500 |
Why?
| | Machine Learning | 1 | 2020 | 442 | 0.490 |
Why?
| | Competitive Behavior | 1 | 2015 | 42 | 0.480 |
Why?
| | Horses | 1 | 2013 | 107 | 0.420 |
Why?
| | Whales | 1 | 2013 | 1 | 0.420 |
Why?
| | Terrorism | 1 | 2012 | 24 | 0.400 |
Why?
| | Women | 3 | 2023 | 52 | 0.400 |
Why?
| | Personnel Selection | 2 | 2024 | 71 | 0.400 |
Why?
| | Sports | 1 | 2015 | 225 | 0.390 |
Why?
| | Probability | 2 | 2015 | 305 | 0.390 |
Why?
| | Universities | 3 | 2024 | 407 | 0.380 |
Why?
| | Students | 1 | 2016 | 579 | 0.350 |
Why?
| | Protozoan Proteins | 3 | 2016 | 75 | 0.350 |
Why?
| | Phylogeny | 2 | 2017 | 849 | 0.340 |
Why?
| | Computer Simulation | 5 | 2024 | 939 | 0.300 |
Why?
| | Adaptation, Biological | 1 | 2009 | 54 | 0.300 |
Why?
| | Birds | 1 | 2009 | 86 | 0.300 |
Why?
| | Politics | 2 | 2021 | 92 | 0.270 |
Why?
| | Neoplasms | 1 | 2021 | 2449 | 0.260 |
Why?
| | Fallopian Tubes | 1 | 2024 | 31 | 0.220 |
Why?
| | Neoplasm Grading | 1 | 2024 | 283 | 0.220 |
Why?
| | Nonlinear Dynamics | 3 | 2017 | 88 | 0.200 |
Why?
| | Humans | 20 | 2024 | 129266 | 0.200 |
Why?
| | Food Chain | 2 | 2016 | 36 | 0.200 |
Why?
| | Socioeconomic Factors | 2 | 2022 | 1209 | 0.180 |
Why?
| | Signal-To-Noise Ratio | 1 | 2021 | 68 | 0.180 |
Why?
| | Diffusion | 1 | 2021 | 116 | 0.180 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2020 | 60 | 0.170 |
Why?
| | Microbiota | 2 | 2017 | 728 | 0.160 |
Why?
| | Computational Biology | 2 | 2014 | 595 | 0.160 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2020 | 379 | 0.160 |
Why?
| | Social Media | 1 | 2021 | 137 | 0.150 |
Why?
| | Prognosis | 2 | 2024 | 3773 | 0.150 |
Why?
| | Censuses | 1 | 2018 | 27 | 0.150 |
Why?
| | Personnel Turnover | 1 | 2018 | 39 | 0.150 |
Why?
| | Neoadjuvant Therapy | 1 | 2020 | 381 | 0.140 |
Why?
| | Canada | 1 | 2018 | 350 | 0.140 |
Why?
| | Publications | 1 | 2017 | 41 | 0.140 |
Why?
| | Sequence Analysis, DNA | 3 | 2015 | 776 | 0.140 |
Why?
| | Aquatic Organisms | 1 | 2016 | 6 | 0.130 |
Why?
| | Predictive Value of Tests | 2 | 2020 | 1949 | 0.130 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 420 | 0.130 |
Why?
| | Genetics, Microbial | 1 | 2015 | 10 | 0.130 |
Why?
| | Age Factors | 1 | 2023 | 3140 | 0.130 |
Why?
| | Datasets as Topic | 1 | 2016 | 109 | 0.130 |
Why?
| | Publishing | 1 | 2017 | 140 | 0.130 |
Why?
| | Plasmodium | 1 | 2015 | 13 | 0.120 |
Why?
| | Gorilla gorilla | 1 | 2015 | 22 | 0.120 |
Why?
| | Biotechnology | 1 | 2015 | 39 | 0.120 |
Why?
| | Pan troglodytes | 1 | 2015 | 58 | 0.120 |
Why?
| | Metabolic Engineering | 1 | 2015 | 28 | 0.120 |
Why?
| | Basketball | 1 | 2015 | 18 | 0.120 |
Why?
| | Quantitative Structure-Activity Relationship | 2 | 2005 | 14 | 0.120 |
Why?
| | Recombination, Genetic | 1 | 2016 | 190 | 0.120 |
Why?
| | Time Factors | 3 | 2015 | 6543 | 0.120 |
Why?
| | Benchmarking | 1 | 2016 | 176 | 0.120 |
Why?
| | Soil Microbiology | 1 | 2017 | 205 | 0.110 |
Why?
| | Host-Parasite Interactions | 1 | 2015 | 103 | 0.110 |
Why?
| | Computer Graphics | 1 | 2014 | 41 | 0.110 |
Why?
| | Biodiversity | 1 | 2017 | 377 | 0.110 |
Why?
| | Female | 8 | 2024 | 68551 | 0.110 |
Why?
| | Internet | 1 | 2018 | 615 | 0.110 |
Why?
| | Animals | 7 | 2017 | 35309 | 0.110 |
Why?
| | Evolution, Molecular | 2 | 2015 | 464 | 0.100 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1556 | 0.090 |
Why?
| | Models, Molecular | 3 | 2005 | 1487 | 0.090 |
Why?
| | Erythrocytes | 1 | 2016 | 673 | 0.090 |
Why?
| | United States | 4 | 2024 | 13826 | 0.090 |
Why?
| | Linear Models | 1 | 2012 | 819 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2737 | 0.080 |
Why?
| | Social Support | 1 | 2013 | 582 | 0.080 |
Why?
| | Biosynthetic Pathways | 1 | 2008 | 24 | 0.070 |
Why?
| | Extinction, Biological | 1 | 2008 | 32 | 0.070 |
Why?
| | Motivation | 1 | 2012 | 546 | 0.070 |
Why?
| | Fossils | 1 | 2008 | 67 | 0.070 |
Why?
| | Species Specificity | 1 | 2009 | 574 | 0.070 |
Why?
| | Genetic Speciation | 1 | 2008 | 75 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 1 | 2008 | 178 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2537 | 0.070 |
Why?
| | Selection, Genetic | 1 | 2008 | 249 | 0.070 |
Why?
| | Pharmacology | 1 | 2005 | 9 | 0.060 |
Why?
| | Gene Regulatory Networks | 1 | 2008 | 280 | 0.060 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2005 | 52 | 0.060 |
Why?
| | Social Behavior | 1 | 2008 | 288 | 0.060 |
Why?
| | Aged | 1 | 2024 | 22032 | 0.060 |
Why?
| | Male | 4 | 2024 | 63512 | 0.060 |
Why?
| | Databases, Factual | 2 | 2013 | 1266 | 0.060 |
Why?
| | Stochastic Processes | 2 | 2014 | 67 | 0.050 |
Why?
| | Sexism | 1 | 2024 | 55 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1839 | 0.050 |
Why?
| | Middle Aged | 1 | 2024 | 31090 | 0.050 |
Why?
| | Receptors, Nicotinic | 1 | 2005 | 329 | 0.050 |
Why?
| | Child | 1 | 2022 | 20785 | 0.050 |
Why?
| | Artificial Intelligence | 1 | 2005 | 246 | 0.050 |
Why?
| | Education, Graduate | 1 | 2022 | 34 | 0.050 |
Why?
| | Protein Binding | 1 | 2008 | 2120 | 0.050 |
Why?
| | Employment | 1 | 2022 | 167 | 0.040 |
Why?
| | Video Recording | 1 | 2021 | 163 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2835 | 0.040 |
Why?
| | Cluster Analysis | 2 | 2014 | 479 | 0.040 |
Why?
| | Geographic Mapping | 1 | 2017 | 21 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2020 | 1199 | 0.030 |
Why?
| | Efficiency | 1 | 2017 | 91 | 0.030 |
Why?
| | Gene Dosage | 1 | 2017 | 143 | 0.030 |
Why?
| | Narration | 1 | 2017 | 57 | 0.030 |
Why?
| | Archaea | 1 | 2017 | 78 | 0.030 |
Why?
| | Ecology | 1 | 2017 | 108 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1869 | 0.030 |
Why?
| | Synteny | 1 | 2015 | 16 | 0.030 |
Why?
| | Plants | 1 | 2017 | 216 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2017 | 521 | 0.030 |
Why?
| | Malaria | 1 | 2014 | 59 | 0.030 |
Why?
| | Malaria, Falciparum | 1 | 2013 | 26 | 0.030 |
Why?
| | Ceramics | 1 | 2013 | 20 | 0.030 |
Why?
| | History, Medieval | 1 | 2013 | 44 | 0.030 |
Why?
| | Southwestern United States | 1 | 2013 | 90 | 0.030 |
Why?
| | Human Migration | 1 | 2013 | 21 | 0.030 |
Why?
| | Geographic Information Systems | 1 | 2013 | 42 | 0.030 |
Why?
| | Archaeology | 1 | 2013 | 34 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2013 | 332 | 0.030 |
Why?
| | Geography | 1 | 2013 | 186 | 0.020 |
Why?
| | Biomarkers | 1 | 2024 | 3968 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 485 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4887 | 0.020 |
Why?
| | Bacteria | 1 | 2017 | 813 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2056 | 0.020 |
Why?
| | Genetic Variation | 1 | 2013 | 938 | 0.020 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2005 | 23 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2005 | 144 | 0.020 |
Why?
| | Drug Design | 1 | 2005 | 156 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2005 | 336 | 0.010 |
Why?
| | Ligands | 1 | 2005 | 621 | 0.010 |
Why?
|
|
Clauset's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|